The latest on menopausal hormone therapy and breast cancer

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Menopause is a normal life stage for women at around 51 years. Most women don’t need treatment for their symptoms, but around 13% of Australian women aged 50-69 take menopausal hormone therapy (sometimes called “hormone replacement therapy”).

This medication contains hormones that are normally low or absent after menopause, and reduces symptoms such as hot flushes and night sweats, which can be troublesome and persistent for some women.

But growing evidence over recent years has pointed to an increased risk of breast cancer associated with menopausal hormone therapy. This has already led some women to stop or avoid the treatment.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Spiros Fourlanos & Samantha Stuk

A/Prof Spiros Fourlanos & Samantha Stuk

Maintaining Muscle Mass & Nutritional Status While Losing Weight on GLP-1RAs

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

Prostate Cancer Screening Recommendations – Case Discussion & Q&A

Dr Alison Chiu

Dr Alison Chiu

Dry Eye – Practical Management Tips for Better Outcome

Dr Ted Wu

Dr Ted Wu

Cardiovascular Outcomes & GLP1 – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Test your knowledge

Recent articles

Latest GP poll

What is your opinion regarding the level of support your paediatric patients with mild to moderate developmental delay or autism receive from the NDIS?

The level of support is inadequate to clinical needs

0%

The level of support is excessive to clinical needs

0%

The level of support is sufficient to clinical needs

0%

I don't have any patients relevant to this question

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Tuesday 30th September, 7pm - 9pm AEST

Speaker

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

Director of Clinical Studies, Ballarat Clinical School at Deakin University

We invite you to our next free webcast, where A/Prof Ralph Audehm & A/Prof Jeremy Grummet offer a Q&A on prostate cancer screening. Up to 4 hours CPD. RACGP & ACRRM accredited.